Floatz logo

Folate

PTSD

Mclean HospitalN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

11 Active assets in the PTSD cohort.

Asset / SponsorPhaseRating
MAGNESIUM METALLICUM
Johns Hopkins University
Phase 4BB
Methylphenidate
VA Office of Research and Development
Phase 4BB
Duloxetine
Yang I. Pachankis, PhD
Phase 4B
Midomafetamine
MAPS Europe B.V.
Phase 2B
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
VA Ann Arbor Healthcare System
Phase 3B

View all 14 →

Same molecule, other indications

Folate is also rated in:

major depressive disorderDormant
BB
Indicative ·
69 / 100
View asset →
anovulationDormant
BB
Indicative ·
69 / 100
View asset →
chronic renal failure syndromeDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →